投融资数据库
免费查数据
注册送3天会员
首页>投融资
Hemogenyx Pharmaceuticals
上市后再融资
Hemogenyx Pharmaceuticals plc is a biopharmaceutical company developing a treatment for blood diseases using a class of cells that can generate cancer-free, patient-matched blood stem cells, which can then be used in bone marrow and blood (hematopoietic) stem cell transplants.
基本信息
-
公司全称Hemogenyx Pharmaceuticals PLC
-
类型生物制药商
-
产业领域医药研发/制造、化学&生物药
-
公司人数15~50人
-
地址6 Heddon Street,London, W1B 4BT
-
联系电话(858)400-8470
-
邮箱@hemogenyx.com
-
成立时间2013-01-01
相关投融资企业
E~PreIPO
Arthrosi Therapeutics LLC focuses on the treatment of uric acid levels and reduce joint damage for people living with gout.In July 2023, Arthrosi Therapeutics secured of $75 million in Series D financing
E~PreIPO
Arthrosi Therapeutics LLC focuses on the treatment of uric acid levels and reduce joint damage for people living with gout.In July 2023, Arthrosi Therapeutics secured of $75 million in Series D financing
收并购
Kronos Bio, Inc.于2017年6月2日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，致力于发现和开发新的癌症疗法，旨在通过针对失调转录的精确药物策略来改变患者的预后。
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息